The aim of this 2-year prospective study was to assess the diagnostic and therapeutic effect of a combined gastro-rheumatological approach in enteropathic spondyloarthritis (eSpA) patients.
Chimenti, M.s., Conigliaro, P., Triggianese, P., Canofari, C., Cedola, F., Onali, S., et al. (2019). Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, EPub 31172920.
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach
Chimenti, Maria Sole;Conigliaro, Paola;Triggianese, Paola;Onali, Sara;Calabrese, Emma;Biancone, Livia;Perricone, Roberto
2019-06-06
Abstract
The aim of this 2-year prospective study was to assess the diagnostic and therapeutic effect of a combined gastro-rheumatological approach in enteropathic spondyloarthritis (eSpA) patients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
